Emma Titmuss

13PUBLICATIONS
81CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 05, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss

|May 16, 2024
Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.

Rebecca J Deyell, Yaoqing Shen, Emma Titmuss

|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree, Emma Titmuss, James T Topham

|Apr 26, 2024
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors.

Emma Titmuss, Irene S Yu, Erin D Pleasance

|Jan 03, 2024
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials.

Joao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss

|Aug 09, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.

Joan Miguel Romero, Emma Titmuss, Yifan Wang

Pageof 3

Frequent Collaborators

10 joint publications

Steven J M Jones

9 joint publications

Marco Marra

7 joint publications

Karen L Mungall

6 joint publications

Jonathan M Loree